Doximity (DOCS) Stock Overview
Operates as a digital platform for medical professionals in the United States. More details
| Snowflake Score | |
|---|---|
| Valuation | 1/6 |
| Future Growth | 3/6 |
| Past Performance | 6/6 |
| Financial Health | 6/6 |
| Dividends | 0/6 |
Rewards
Risk Analysis
No risks detected for DOCS from our risk checks.
DOCS Community Fair Values
Create NarrativeSee what 58 others think this stock is worth. Follow their fair value or set your own to get alerts.
Doximity, Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$64.02 |
| 52 Week High | US$85.21 |
| 52 Week Low | US$34.34 |
| Beta | 1.36 |
| 1 Month Change | 4.01% |
| 3 Month Change | 9.53% |
| 1 Year Change | 80.39% |
| 3 Year Change | 83.28% |
| 5 Year Change | n/a |
| Change since IPO | 20.79% |
Recent News & Updates
Recent updates
Doximity: Slowing Sales And EBITDA Growth
Jul 23Getting In Cheap On Doximity, Inc. (NYSE:DOCS) Is Unlikely
Jul 08
With EPS Growth And More, Doximity (NYSE:DOCS) Makes An Interesting Case
Jun 23At US$52.56, Is Doximity, Inc. (NYSE:DOCS) Worth Looking At Closely?
May 17Calculating The Intrinsic Value Of Doximity, Inc. (NYSE:DOCS)
May 01Shareholders Are Optimistic That Doximity (NYSE:DOCS) Will Multiply In Value
Apr 04What Doximity, Inc.'s (NYSE:DOCS) 28% Share Price Gain Is Not Telling You
Feb 23Doximity Q3 Earnings: Outpacing Even Management's Expectations
Feb 10When Should You Buy Doximity, Inc. (NYSE:DOCS)?
Jan 24Doximity: Upgraded To Buy Amid Promising Growth And Strong Execution
Jan 13Here's Why We Think Doximity (NYSE:DOCS) Is Well Worth Watching
Jan 06Doximity: Strong Fundamentals And Growth Potential Makes It Attractive
Dec 06Doximity (NYSE:DOCS) Knows How To Allocate Capital
Dec 01Earnings Not Telling The Story For Doximity, Inc. (NYSE:DOCS) After Shares Rise 34%
Nov 13Does This Valuation Of Doximity, Inc. (NYSE:DOCS) Imply Investors Are Overpaying?
Nov 02Is Doximity, Inc. (NYSE:DOCS) Potentially Undervalued?
Oct 15Doximity: Downgrade To Hold On Valuation Concerns
Oct 03Here's Why Doximity (NYSE:DOCS) Has Caught The Eye Of Investors
Sep 23
Generative AI And Digital Health Innovations Fuel Robust Revenue Growth And Market Expansion
Accelerating adoption of new products and a client portal, alongside strategic positioning with top clients, suggests sustained revenue expansion.There's Reason For Concern Over Doximity, Inc.'s (NYSE:DOCS) Massive 27% Price Jump
Aug 18Doximity Faces Slower Revenue Growth As R&D Costs May Rise
Jul 23Doximity Earnings: Better Than Expected, But Still Mixed Outlook (Rating Upgrade)
May 17Doximity: Significant Upside Remains, But Not Until The Growth Story Returns
Apr 29Doximity: Rating Upgrade To Buy As Outlook Turns Positive
Feb 21Doximity: Downside Is Contained, While Upside Depends On Management's Game Plan
Jan 16Shareholder Returns
| DOCS | US Healthcare Services | US Market | |
|---|---|---|---|
| 7D | 10.1% | 1.2% | 1.9% |
| 1Y | 80.4% | 28.8% | 19.4% |
Return vs Industry: DOCS exceeded the US Healthcare Services industry which returned 24.5% over the past year.
Return vs Market: DOCS exceeded the US Market which returned 19.6% over the past year.
Price Volatility
| DOCS volatility | |
|---|---|
| DOCS Average Weekly Movement | 7.0% |
| Healthcare Services Industry Average Movement | 8.5% |
| Market Average Movement | 6.4% |
| 10% most volatile stocks in US Market | 17.6% |
| 10% least volatile stocks in US Market | 3.1% |
Stable Share Price: DOCS has not had significant price volatility in the past 3 months compared to the US market.
Volatility Over Time: DOCS's weekly volatility (7%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2010 | 830 | Jeff Tangney | www.doximity.com |
Doximity, Inc. operates as a digital platform for medical professionals in the United States. Its platform provides its members with digital tools built for medicine, that enables its members to collaborate with colleagues, stay up to date with the latest medical news and research, manage their careers and on-call schedules, streamline documentation and administrative paperwork, and conduct virtual patient visits. The company primarily serves physicians, nurse practitioners, physician assistants, medical students, pharmaceutical manufacturers, and healthcare systems.
Doximity, Inc. Fundamentals Summary
| DOCS fundamental statistics | |
|---|---|
| Market cap | US$11.58b |
| Earnings (TTM) | US$235.13m |
| Revenue (TTM) | US$589.64m |
Is DOCS overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| DOCS income statement (TTM) | |
|---|---|
| Revenue | US$589.64m |
| Cost of Revenue | US$58.12m |
| Gross Profit | US$531.52m |
| Other Expenses | US$296.39m |
| Earnings | US$235.13m |
Last Reported Earnings
Jun 30, 2025
Next Earnings Date
n/a
| Earnings per share (EPS) | 1.26 |
| Gross Margin | 90.14% |
| Net Profit Margin | 39.88% |
| Debt/Equity Ratio | 0% |
How did DOCS perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/08/13 05:39 |
| End of Day Share Price | 2025/08/13 00:00 |
| Earnings | 2025/06/30 |
| Annual Earnings | 2025/03/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Doximity, Inc. is covered by 27 analysts. 19 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Vikram Kesavabhotla | Baird |
| Nisala Weerasuriya | Berenberg |
| Allen Lutz | BofA Global Research |